Carbapenemase-producing Enterobacteriaceae in Europe: assessment by national experts from 38 countries, May 2015
Journal
Euro Surveillance
Date Issued
2015-11
Author(s)
B Albiger
C Glasner
MJ Struelens
H Grundmann
DL Monnet
The European Survey of Carbapenemase-Producing Enterobacteriaceae (EuSCAPE) working group
DOI
10.2807/1560-7917.ES.2015.20.45.30062
Abstract
In 2012, the European Centre for Disease Prevention
and Control (ECDC) launched the ‘European survey
of carbapenemase-producing Enterobacteriaceae
(EuSCAPE)’ project to gain insights into the occur rence and epidemiology of carbapenemase-producing
Enterobacteriaceae (CPE), to increase the awareness of
the spread of CPE, and to build and enhance the labo ratory capacity for diagnosis and surveillance of CPE in
Europe. Data collected through a post-EuSCAPE feed back questionnaire in May 2015 documented improve ment compared with 2013 in capacity and ability to
detect CPE and identify the different carbapenemases
genes in the 38 participating countries, thus contrib uting to their awareness of and knowledge about the
spread of CPE. Over the last two years, the epidemio logical situation of CPE worsened, in particular with
the rapid spread of carbapenem-hydrolysing oxacil linase-48 (OXA-48)- and New Delhi metallo-beta lactamase (NDM)-producing Enterobacteriaceae. In
2015, 13/38 countries reported inter-regional spread
of or an endemic situation for CPE, compared with
6/38 in 2013. Only three countries replied that they
had not identified one single case of CPE. The ongo ing spread of CPE represents an increasing threat to
patient safety in European hospitals, and a majority of
countries reacted by establishing national CPE surveil lances systems and issuing guidance on control meas ures for health professionals. However, 14 countries
still lacked specific national guidelines for prevention
and control of CPE in mid-2015
and Control (ECDC) launched the ‘European survey
of carbapenemase-producing Enterobacteriaceae
(EuSCAPE)’ project to gain insights into the occur rence and epidemiology of carbapenemase-producing
Enterobacteriaceae (CPE), to increase the awareness of
the spread of CPE, and to build and enhance the labo ratory capacity for diagnosis and surveillance of CPE in
Europe. Data collected through a post-EuSCAPE feed back questionnaire in May 2015 documented improve ment compared with 2013 in capacity and ability to
detect CPE and identify the different carbapenemases
genes in the 38 participating countries, thus contrib uting to their awareness of and knowledge about the
spread of CPE. Over the last two years, the epidemio logical situation of CPE worsened, in particular with
the rapid spread of carbapenem-hydrolysing oxacil linase-48 (OXA-48)- and New Delhi metallo-beta lactamase (NDM)-producing Enterobacteriaceae. In
2015, 13/38 countries reported inter-regional spread
of or an endemic situation for CPE, compared with
6/38 in 2013. Only three countries replied that they
had not identified one single case of CPE. The ongo ing spread of CPE represents an increasing threat to
patient safety in European hospitals, and a majority of
countries reacted by establishing national CPE surveil lances systems and issuing guidance on control meas ures for health professionals. However, 14 countries
still lacked specific national guidelines for prevention
and control of CPE in mid-2015
File(s)![Thumbnail Image]()
Loading...
Name
Euro Surveillance-CPE-2015.pdf
Size
2.87 MB
Format
Adobe PDF
Checksum
(MD5):d4e6812c33d1b277a5a6bdd51392853d